Former Union Cabinet Minister Shri Mukhtar Abbas Naqvi today said here that “ABC” (After & Before Corona) should be the parameter of success of the Indian Pharma industry.
Addressing “Conference on Regulatory Compliances in Pharma”, organised by PHD Chamber of Commerce and Industry in New Delhi, Shri Naqvi said that when the Corona pandemic had shaken the entire world; the passion, productivity and performance of the Indian Pharma fraternity played a paramount role in keeping the citizens of the country safe as well as ensuring health and well-being of the entire humanity. Shri Naqvi said that the Indian Pharma industry has been globally admired as a “trouble-shooter” warrior through the timely and effective availability of life-saving medical facilities to fight and win the Corona war.
Shri Naqvi said that India's culture and Prime Minister Shri Narendra Modi’s commitment to “Sarve Bhavantu Sukinah, Sarve Santu Niramaya” (May all be happy and prosperous, all be free from disease and sorrow), has resulted into India becoming a successful, sincere, selfless, spirited, accessible and affordable “protector” of health of the entire Humanity.
Shri Naqvi said that the Modi Government has taken several important steps for ease of doing business in the health sector to provide affordable and quality medical facilities for all especially weaker sections of the society.
Shri Naqvi said that we believe in the welfare of Hindustan along with the entire Humanity; this zeal stood the test of time during the Corona crisis. India not only launched the world’s largest vaccination drive by administering more than 220 crore doses of Corona vaccines to its citizens; it also supplied Corona vaccines to more than 150 countries. The Indian Pharma industry has proved to be a “Health Hamper” for the entire world.
Shri Naqvi said that India’s recognition and reputation as "Pharmacy of the World", once again proved during the global Corona crisis, must be maintained and there should be no compromise with the quality in the Indian Pharma industry.
Shri Naqvi said that India has ample talent and resources for innovation and research in the pharma sector. The Indian Pharma industry has grown at the rate of 8 percent during the last 5 years and it is estimated to touch worth 57 billion Dollars by 2025. Union Minister of State for Health and Family Welfare Prof. S P Singh Baghel also graced the occasion. More than 100 pharma manufacturers, PHD Chamber of Commerce & Industry members, officials associated with pharma regulations from different countries including the US, Britain, Russia, Ukraine and other experts from the pharma industry attended this conference which discussed the latest trends in regulatory compliance as well as the best practices for staying compliant.